Genetic Technologies Announces Agreement To Acquire EasyDNA From BelHealth Investment Fund LP As Majority Owner For $4M In Cash And GTG ADRs
Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, &ldquo, Company&rdquo, , &ldquo, GTG&rdquo, )), a global leader in Genomics tests in health, wellness and serious disease, has signed an agreement to acquire the